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To elucidate roles of heme oxygenase-1 (HO-1) in cardiovascular system, we have analyzed one-year-old HO-1-knockout mice.
Homozygous HO-1-knockout mice had severe aortitis and coronary arteritis with mononuclear cellular inﬁltration and fatty
streak formation even on a standard chow diet. Levels of plasma total cholesterol and HDL were similar among the three
genotypes. However, homozygous HO-1-knockout mice had lower body weight and plasma triglyceride. HO-1-deﬁciency resulted
in alteration of the composition of HDL. The ratio of apolipoprotein AI to AII in HO-1-knockout mice was reduced about 10-fold
as compared to wild-type mice. In addition, paraoxonase, an enzyme against oxidative stress, was reduced less than 50% in HO-
1-knockout mice. The knockout mice also exhibited signiﬁcant elevation of plasma lipid hydroperoxides. This study using aged
HO-1-knockout mice strengthened the idea that HO-1 functions to suppress systemic inﬂammation in artery wall and prevents
plasma lipid peroxidation.
1.Introduction
Heme oxygenase (HO) oxidatively catalyzes heme to bil-
iverdin, carbon monoxide, and free iron using NADPH-
cytochrome P450 reductase as an electron donor [1–3]. A
number of studies suggest a potential protective function of
thisenzymeagainstoxidative stressundervariousconditions
with transcriptional activation of heme oxygenase-1 (HO-1)
[4, 5]. The antioxidant activity of HO derives from both the
elimination of prooxidant heme and the biological activities
of its products. Biliverdin and its metabolite by biliverdin
reductase, bilirubin, eﬀectively inhibit LDL oxidation [6,
7]. Free iron regulates ferritin synthesis through an iron-
responsive element [8]. Ferritin has been shown to have
cytoprotective eﬀects against oxidative injuries [9]. Carbon
monoxide (CO) modulates the activity of soluble guanylate
synthetase like nitric oxide [10] and p38 mitogen-activated
kinase activity [11].
Accumulating evidence suggests that oxidized LDL
(oxLDL) plays an important role during the early phases
of atherogenesis via its proinﬂammatory properties [5].
We recently reported that HO-1 is remarkably induced by
mildly oxLDL in both endothelial cells and smooth muscle
cells [12]. HO-1 expression was also highly responsive to
oxidized bioactive oxidized phospholipids existing in LDL
[12]. In addition, using artery wall cocultures we found
that HO-1 inhibits oxLDL-dependent monocyte chemotaxis
through its products bilirubin and biliverdin [12]. We then
performedinvivostudiestoexaminetheroleofHO-1onthe
development of atherosclerosis. HO-1 was highly expressed
in atherosclerotic lesion in C57BL/6J, apoE-knockout, and
LDL-receptor-knockout mice [13]. When we modulate HO
expression in high-fat-fed LDL-receptor knockout mice,
HO inhibition signiﬁcantly resulted in the progression of
atherosclerotic lesion formation compared to the mice in
which HO was induced [13]. These results lead us to
hypothesize the protective roles of HO-1 for atherogenesis.
High-density lipoproteins (HDLs) are considered to
work for antiatherogenesis. These antiatherogenic properties
have been explained by reverse cholesterol transport from2 International Journal of Hypertension
cells to liver [14]. However, previous studies revealed that
HDL itself works as an antioxidant for minimally oxidized
low-density lipoproteins [15] and that paraoxonase and
apolipoprotein AI in HDL play an important role as
antioxidants [16, 17]. However, it is reported that oxidative
modiﬁcation of HDL loses the eﬀect to stimulate eﬄux of
cholesterol from foam cells [18] and that oxidized HDL
activates platelets similar to oxidized LDL [19].
To further strengthen the idea that HO-1 functions
as an anti-inﬂammatory enzyme in artery wall and that
HO-1 exhibits antioxidative eﬀects on plasma lipoproteins,
we analyzed one-year-old HO-1-knockout mice bred on a
standard chow diet. Studies using HO-1 knockout mice
[4, 20, 21] revealed that (i) HO-1-homozygous-knockout
(HO-1−/−) mice develop an anemia with accumulation of
iron in liver and kidney, (ii) cultured HO-1−/− embryonic
ﬁbroblasts produce high free radicals when exposed to
hydrogen peroxides, paraquat, or cadmium chloride, (iii)
HO-1−/− mice are vulnerable to mortality when challenged
with endotoxin, and (ix) HO-1 expression ensures to survive
cardiac xenograft.
In this study, we examined artery walls and plasma lipo-
proteins of male HO-1-knockout mice between 1- and 1.5-
year old which were bred on a standard chow diet. HO-1-
knockout mice had severe inﬁltration of mononuclear cells
at their ascending aortic wall and coronary arteries and small
atherosclerotic lesion in aortic sinus. In HO-1 knockout
mice, HDL appears to be oxidized. Furthermore, the com-
position of apolipoprotein AI and AII in HDL altered. These
results show HDL oxidation in HO-1-knockout mice. In ad-
dition, HO-1-knockout mice showed lower plasma paraoxo-
nase level and higher lipid peroxide level, suggesting that the
absence of HO-1 resulted in the oxidation of plasma lipo-
proteinsandactivateinﬂammatoryresponsesinarterialwall.
2.MaterialsandMethods
2.1. Reagents. Reagents utilized were obtained from Sigma
unless otherwise speciﬁed.
2.2. Animal Handling and Procedures. All animal experi-
ments were conducted in accordance with the guidelines
of the UCLA and Fukushima Medical University Animal
Research Committee. The generation of mice containing
targeted disruption of the HO-1 gene was done as previously
described [4]. HO-1-deﬁcient mice were generated with
C57BL/6J and 129/sv mixed genetic background. C57BL/6J
mice for backcross were purchased from the Jackson Lab-
oratory (Bar Harbor, ME). The mice were fed a standard
rodent chow diet containing 4% (wt/wt) fat and <0.04%
(wt/wt) cholesterol (Oriental Bio, Tsukuba, Japan). Animals
were housed four to ﬁve per cage and maintained in a
temperature-controlled room with a 12-hour light/dark cy-
cle,andanimalswerestrictlymonitoredformicroorganisms.
2.3. Atherosclerotic Lesion Analysis. Following sacriﬁce, the
heart and proximal aorta were excised and washed in
phosphate-buﬀered saline to remove blood. The basal por-
tion of the heart and proximal aorta were embedded in OCT
compound (Tissue Tek, Elkhart, IN), frozen on dry ice, and
stored at −70◦C until they were sectioned. Serial 10-µm
cryosections were collected on poly-D-lysine-coated slides,
stained with oil red O and hematoxylin, and examined by
light microscopy. Atherosclerotic lesion area was calculated
usingserialsectionsoftheﬁrst400µmoftheascendingaorta
aspreviouslydescribed [22].Hematoxylin-eosinandElastica
Van Gieson staining were done with the paraformaldehyde
ﬁxed sections.
2.4. Hematocrit, Plasma Lipoprotein Analyses, and Lipid Per-
oxidation Assay. Blood was collected from the retro-orbital
plexus of mice fasted overnight using heparin-coated capil-
laries (Fisher Scientiﬁc) into a heparin-treated Microtainer
tube (Becton Dickinson) and centrifuged at 4◦C. The hema-
tocrit was determined by the use of capillary microhemat-
ocrit technique in blood obtained. Plasma cholesterol and
triglycerideconcentrationsweredeterminedenzymaticallyas
described previously [23].
2.5.PlasmaLipoproteinsandLipidAnalyses. Lipoproteinfrac-
tionsfrompooledmiceplasmawereisolatedbyfastperform-
ance liquid chromatography [23]. Lipoprotein concentra-
tions are expressed according to their protein content. The
characterization of isolated HDL fractions from mouse plas-
mahaspreviouslyreported[24].Theproteincontentoflipo-
proteinswasmeasuredusingthemethodofLowryetal.[25].
HDL fraction was electrophoresed by 1% agarose gel and
stained with Nile Red. SDS-PAGE with 4–20% gradient gel
was performed according to the procedure of Laemmli [26].
2.6. Paraoxonase Assay. Paraoxonase activities were assayed
using paraoxon as substrate [27]. The cuvette contained
1.0mM paraoxon in 20mM Tris/HCl (pH 8.0). The reaction
was initiated by the addition of the plasma, and the increase
in the absorbance at 405nm was recorded. Blanks were
included to correct for spontaneous hydrolysis of paraoxon.
Enzymatic activity was calculated from the molar extinction
coeﬃcient 1310M−1 cm−1. 1 unit of paraoxonase activity is
deﬁned as 1nmol of 4-nitrophenol formed per min under
the above assay conditions [27]. For puriﬁed paraoxonase
standard solutions, paraoxonase isoforms were isolated as
described previously [27].
2.7. Other Procedures. Plasma lipid peroxidation as a mal-
ondialdehyde was measured with a kit from Oxis (Portland,
O R ) .A l lv a l u e sa r ee x p r e s s e da sm e a n s± SD. Signiﬁcant
diﬀerence was determined by one-way ANOVA analysis with
Fisher’s post hoc test. P<0.05 was considered signiﬁcant.
3. Results and Discussion
3.1. Aortitis, Coronary Arteritis, and Atherosclerosis in HO-1-
Knockout Mice. To elucidate the eﬀe c to fH O - 1o nv a s c u l a r
system, we examined male HO-1-knockout mice aged over
1 year which were bred on a standard rodent chow diet.International Journal of Hypertension 3
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Figure 1: Severe aortitis, coronary arteritis and small atherosclerotic lesion on a standard rodent chow diet after 1 year old of HO-1−/− mice.
(a, g, h) Oil red O staining. (b, c, e, f) Hematoxylin- eosin staining. (d) Elastica Van Gieson staining. (d) Elastic ﬁbers in the vessel walls are
torn at the site of severe mononuclear cell inﬁltration. Magniﬁcations at (a, e) ×40, (b) ×100, (c, d) ×200, and (f, g, h) ×400. Predominant
sitesofaortitis(b,c,d)andinitialfattystreakformation(h)areindicatedbyarrows.Thesephotomicrographsarerepresentativeofnumerous
sections examined.
Table 1: Body weight and plasma lipid levels of HO-1-knockout
mice.
HO-1 genotype +/+(n = 7) +/−(n = 6) −/−(n = 5)
Body weight (g) 45.6 ± 4.3 43.8 ± 3.8 30.6 ± 3.9∗
Hematocrit (%) 46 ± 44 4 ± 24 1 ± 2
Total cholesterol (mg/dL) 92 ± 18 87 ± 11 86 ± 15
Triglyceride (mg/dL) 106 ± 38 26 ± 41 4 ± 3∗
HDL-cholesterol (mg/dL) 73 ± 87 2 ± 11 65 ± 9
Free Fatty Acid (mg/dL) 43 ± 74 1 ± 83 6 ± 3
Lipid levels are given in mg/dL ± S.D. Values for lipid levels on a standard
chow diet were from mice of 50% C57BL/6 and 50% 129/Sv genetic
background. ∗P<0.05.
These mice had a mixed genetic background of 129Sv
and C57BL/6J. HO-1−/− mice had severe inﬁltration of
mononuclear cells at their ascending aortic wall (100%)
(Figures1(a)and1(b)).Thisinﬁltrationwastransmural,and
the intimal elastic laminal structure was severely destroyed
(Figures 1(c), and 1(d)). This mononuclear cellular inﬁltra-
tion was not only observed at aorta but also observed at
coronary arteries (Figures 1(e), 1(f), and 1(g)). Oil red O
staining revealed small atherosclerotic lesion in aortic sinus
of HO-1−/− mice even under a standard chow diet though
wild-type mice did not develop such lesions (Figure 1(h)).
These inﬂammatory changes of arteries were also observed
in heterozygous mice; however, this was less frequently. It
is unclear whether these arterial inﬂammations in HO-1-
deﬁcient mice are the response against microorganisms or
autoimmune response [28].
3.2. Altered HDL Properties in HO-1-Knockout Mice.
Table 1 shows body weights and plasma lipid levels of4 International Journal of Hypertension
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Figure 2: (a) Agarose electrophoresis of HDL in HO-1-knockout mice. 11µg protein of HDL fraction was electrophoresed in 1% agarose
gel and stained with Nile Red. (b) Change of Apolipoprotein AI/AII ratio in HO-1-knockout mice. 1µg protein HDL was subjected to
SDS-PAGE and stained with Nile Red.
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Figure 3: (a) Plasma paraoxonase activities in HO-1-knockout mice. PON activities were determined using arylesterase as substrate and are
given as a percentage ± S.D. (b) Plasma lipid hydroperoxide levels in HO-1-knockout mice. Estimates of lipid peroxidation products were
obtained by malondialdehyde (MDA) measurements of plasma. Data represents mean ± S.D. from duplicate. Asterisks represent statistically
signiﬁcant diﬀerences (∗P<0.05, ∗∗P<0.01).
HO-1-knockout mice analyzed. HO-1−/− mice were signif-
icantly lighter than HO-1 wild-type (HO-1+/+) and HO-
1-heterozygous-knockout (HO-1+/−) mice. There were no
diﬀerencesintotalcholesterol,HDL,andfreefattyacidlevels
among three genotypes; however, triglyceride levels of HO-
1−/− and HO-1+/− were much lower than those of HO-
1+/+ mice. HDLs were prepared by discontinuous density
gradient ultracentrifugation from pooled fresh plasma of
each genotype, electrophoresed on 1% agarose gel and
stained with Nile Red. 11µg HDL of HO-1−/− and +/− mice
runs faster than that of HO-1+/+ mice, suggesting HDLs
of HO-1−/− and +/− m i c ea r em o r en e g a t i v e l yc h a r g e do r
smaller in size (Figure 2(a)). To examine the composition
of apolipoproteins in HDL, 1µg HDL was subjected to 4–
20% SDS-PAGE gel. The ratios of apolipoprotein AI and
apolipoprotein AII were diﬀerent among three genotypes
(Figure 2(b)). Apolipoprotein AI was major protein in HO-
1+/+, whereas apolipoprotein AII was a major in HO-1−/−
mice. The ratios of apolipoprotein AI to AII were 2.6,
1.1, and 0.2 in HO-1+/+, +/−,a n d−/− mice, respectively,
by densitometric analyzes. There are more than 10-fold
changes of the ratio of apolipoprotein AI to AII between
HO-1+/+ and HO-1−/− mice. Studies using transgenic mice
models suggested that apolipoprotein AI is antiatherogenic
[29] and apolipoprotein AII is atherogenic [23]. Though we
cannot explain the mechanism why the absence of HO-1International Journal of Hypertension 5
resulted in the compositional change of HDL and produced
oxidized HDL, it may be possible to understand HO-1
functions to prevent HDL particle and apolipoproteins from
oxidative stress. It is reported that apolipoprotein AI starts
denaturation and is easy to make oligomers in oxidized HDL
[30]. However, in this study, we did not ﬁnd oligomeric
bands. It will be also interesting to examine whether HO-
1−/− mice have more susceptibilities to atherogenesis by
high-fat diet challenges.
Paraoxonase is a calcium-dependent esterase that is
known to catalyze hydrolysis of organophosphates and wide-
ly expressed in the liver, kidney, intestine, and plasma [31].
Paraoxonase has been suggested to contribute to antioxidant
protection of HDL to LDL oxidation in vitro [32] and in
vivo [33]. HO-1−/− mice had decreased plasma paraox-
onase activity less than 50% compared to HO-1+/+ mice
(Figure 3(a)). This reduced paraoxonase activity may imply
that HDL in HO-1−/− mice was suﬀered by stronger oxida-
tive stress. There may be unknown relationship between
reduced paraoxonase activity and the compositional changes
of apolipoprotein AI to AII. Plasma lipid peroxides levels
of HO-1−/− mice were higher than those of HO-1+/+ mice
(Figure 3(b)), suggesting that HO-1 functions to suppress
lipoprotein oxidation presumably by production of antiox-
idants, biliverdin and bilirubin.
Over 95% of HO-1−/− mice die in utero with unknown
reason [4]. It may be not easy for HO-1−/− mice to
survive without intrinsic antioxidant systems although the
reason only a part of those survives is not still clear. In
addition, changes in HO-1−/− mice such as lower body
weight and decrease of plasma triglyceride need to be further
examined by analyzing food consumption and metabolic
rate.However,ourdatausingHO-1−/− micedirectlysuggests
a signiﬁcant function of HO-1 as an anti-inﬂammatory
molecule in artery wall and for native HDL.
Abbreviations
HO: Heme oxygenase
HDL: High-density lipoprotein
LDL: Low-density lipoprotein
oxLDL: Oxidized LDL
−/−: Homozygous knockout
+/−: Heterozygous knockout
+/+: Wild type.
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